March 14, 2017
The Massachusetts ADRC, Harvard NeuroDiscovery Center and the MGH Neurology Clinical Trials Unit have joined forces to fund the best novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including the affiliated hospitals and institutions. In addition, investigators from the University of Massachusetts community are encouraged to submit ALS-related purposals. Grants with a dollar value up to $40,000 (direct costs) will be awarded for the duration of one-year. A total of $400,000 is available.
Applications will be judged on the basis of scientific merit, novelty and the value of the project in obtaining preliminary data that could lead to sponsored research (investigator-initiated R01 research grants, career development awards, industry or foundation support). Availability of appropriate facilities and the technical ability to carry out the project are fundamental. Clinical projects as well as basic research will be considered. Priority will be given first to junior investigators, then to senior investigators who are new to neurodegenerative disease research, and finally, to established investigators with a new line of investigation that lacks funding. Use of Harvard NeuroDiscovery Center cores, ADRC cores or MGH Neurology Clinical Trials Unit resources is strongly encouraged.
All applications should be prepared according to the same rules and criteria and submitted electronically to email@example.com by 5pm November 18th, 2011.
More information on the program may be found at neurodiscovery.harvard.edu
Applications Due Date: November 18, 2011
Recipients Announced: December 15, 2011
Awards Start: January - April 2012